Gu, Chao <br/><br/>
Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer.  [electronic resource] 

 -  Cancer science  Mar 2011 
 - 557-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1349-7006 
<br/><br/><label>Standard No.: </label>10.1111/j.1349-7006.2010.01829.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Hormonal--pharmacology<br/>Cell Line, Tumor<br/>Chromones--pharmacology<br/>Drug Resistance, Neoplasm<br/>Endometrial Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Medroxyprogesterone Acetate--pharmacology<br/>Mice<br/>Mice, Inbred BALB C<br/>Morpholines--pharmacology<br/>Phosphatidylinositol 3-Kinases--physiology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Receptors, Progesterone--analysis<br/>Signal Transduction--drug effects